← Leaderboards
Rainer Ng
University Of Washington
$5,642,189
Attributed
$5,642,189
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,642,189 · 7
By mechanism
R44$4,933,106 · 4
N43$599,409 · 2
F32$109,674 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Frantisek Turecek$4,061,079
- Clifford R. Scott$2,323,493
- Michael H Gelb$24,827,130
- Beate Peter$1,293,052
- Richard Partridge Wennberg$503,483
Others in their field
Top investigators on “Laboratories”
- David Heimbrook · Leidos Biomedical Research, Inc.$943,075,715
- Lawrence Corey · Fred Hutchinson Cancer Center$747,603,944
- Jeffrey P Krischer · University Of South Florida$627,303,958
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$553,634,937
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
Research focus
LaboratoriesTechnologyScreeningNewborn InfantBaseMicrofluidicsRunningDigitalPerformanceInnovationInstrumentTranslatingAffectPreparationSamplingBlood SpecimenMethodologyNeonatal ScreeningGoldLifeLongevityDesignLeadGenes
Grant awards (13)
A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance$1,000,723
R44 · FY2025 · AI · contact PI
A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance$300,000
R44 · FY2025 · AI · contact PI
Development of a Rapid, Quantitative HIV-1 Assay for Viral Load Self-Monitoring$299,427
N43 · FY2025 · AI · contact PI
A Simple Multiplexed Platform for Self-Administered HIV and Hepatitis B Testing$299,982
N43 · FY2024 · AI · contact PI
Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses$703,049
R44 · FY2022 · HD · contact PI
A Novel Workflow to Screen for Illicit Drug Exposure in Newborns$672,757
R44 · FY2021 · DA · contact PI
Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses$628,742
R44 · FY2021 · HD · contact PI
A Low Blood Volume Platform for Global Newborn Screening of Common, Treatable Conditions$717,391
R44 · FY2020 · HD · contact PI
A Novel Workflow to Screen for Illicit Drug Exposure in Newborns$716,018
R44 · FY2020 · DA · contact PI
Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses$194,426
R44 · FY2020 · HD · contact PI
Calcium and oxidative stress in muscular dystrophy$6,158
F32 · FY2012 · AR · contact PI
Calcium and oxidative stress in muscular dystrophy$53,042
F32 · FY2011 · AR · contact PI
Calcium and oxidative stress in muscular dystrophy$50,474
F32 · FY2010 · AR · contact PI